1 results match your criteria: "KS (A.D.); and Boston University[Affiliation]"
Indian Trial of Tranexamic acid in Spontaneous Intracerebral Hemorrhage study protocol.
Int J Stroke
January 2025
Indian Council of Medical Research, Non-Communicable Diseases Section, New Delhi, India.
Rationale: Early mortality in intracerebral hemorrhage (ICH) is due to hematoma volume (HV) expansion, and there are no effective treatments available other than reduction in blood pressure. Tranexamic acid (TXA) a hemostatic drug that is widely available and safe can be a cost-effective treatment for ICH, if proven efficacious.
Hypothesis: Administration of TXA in ICH patients when given within 4.